Please use this identifier to cite or link to this item: https://repositorio.usj.es/handle/123456789/514

Full metadata record
DC FieldValueLanguage
dc.contributor.authorNuggerud-Galeas, Shysset-
dc.contributor.authorSáez-Benito, Loreto-
dc.contributor.authorBerenguer, Núria-
dc.contributor.authorSuescún, Ana Victoria-
dc.contributor.authorAguilar-Latorre, Alejandra-
dc.contributor.authorMagallon-Botaya, Rosa-
dc.contributor.authorOliván-Blázquez, Bárbara-
dc.date.accessioned2021-03-02T13:02:08Z-
dc.date.available2021-03-02T13:02:08Z-
dc.date.issued2020-05-21-
dc.identifier.citationNuggerud-Galeas S, Sa´ez-Benito Suescun L, Berenguer Torrijo N, Sa´ez-Benito Suescun A, Aguilar-Latorre A, Magallo´n Botaya R, et al. (2020) Analysis of depressive episodes, their recurrence and pharmacologic treatment in primary care patients: A retrospective descriptive study. PLoS ONE 15(5): e0233454. https://doi.org/10.1371/ journal.pone.0233454es_ES
dc.identifier.issn1932-6203es_ES
dc.identifier.urihttps://repositorio.usj.es/handle/123456789/514-
dc.description.abstractBackground Depression is one of the most prevalent health problems, frequently being a medium- and long-term condition, with a high comorbidity rate and with frequent relapses and recurrences. Although numerous studies have compared the effectiveness of specific antidepressant therapy drugs and have assessed relapses, scientific evidence on the relationship between pharmacologic treatments and recurrence is scarce. The objective of this study is to describe depressive episodes in a primary care patient cohort, the percentage of depression recurrences and the administered pharmacologic treatment, from a naturalistic perspective. Methods Retrospective descriptive study. 957 subjects were included. The dependent variable was a depression diagnosis and independent variables were: gender, age at time of data collection; age of onset, first-episode treatment, number of recurrences, age at recurrences, treatment prescribed for recurrences using therapeutic groups categorization. Results Recurrences are frequent, affecting more than 40% of the population. In the first episode, 13.69% of the patients were not prescribed pharmacological treatment, but this percentage decreased over the following depression episodes. 80.9% of the patients who did not receive drug treatment in the first depression episode did not experience subsequent episodes. Monotherapy, and specifically, SSRIs were the most frequently prescribed treatment option for all depressive episodes. Regards the combined pharmacologic treatment, the most frequent drug combinations were SSRIs and benzodiazepines.Limitations In order to increase the power of results, the statistical analysis was performed using therapeutic groups categorization, not individually analyzing each drug and dose. Conclusions Depressive episode recurrence is frequent in primary care patients. Further studies having a prospective design are needed in order to expand on this issue.es_ES
dc.format.extent15 p.es_ES
dc.format.mimetypeapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherPUBLIC LIBRARY SCIENCEes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleAnalysis of depressive episodes, their recurrence and pharmacologic treatment in primary care patients: A retrospective descriptive studyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.identifier.doi10.1371/journal.pone.0233454es_ES
dc.rights.accessrightsinfo:eu-repo/semantics/openAccesses_ES
Appears in Collections:Artículos de revistas



This item is licensed under a Creative Commons License Creative Commons